174 related articles for article (PubMed ID: 32435795)
1. UPLC-MS-Based Procedures to Detect Prolyl-Hydroxylase Inhibitors of HIF in Urine.
Mazzarino M; Perretti I; Stacchini C; Comunità F; de la Torre X; Botrè F
J Anal Toxicol; 2021 Feb; 45(2):184-194. PubMed ID: 32435795
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
3. Detection of 5α-reductase inhibitors by UPLC-MS/MS: Application to the definition of the excretion profile of dutasteride in urine.
Mazzarino M; Martellone L; Comunità F; de la Torre X; Molaioni F; Botrè F
Drug Test Anal; 2019 Nov; 11(11-12):1737-1746. PubMed ID: 31747487
[TBL] [Abstract][Full Text] [Related]
4. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine by liquid chromatography-mass spectrometry-based techniques.
Stacchini C; Botrè F; Comunità F; de la Torre X; Dima AP; Ricci M; Mazzarino M
J Pharm Biomed Anal; 2021 Feb; 195():113849. PubMed ID: 33383501
[TBL] [Abstract][Full Text] [Related]
6. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of hypoxia inducible factor-prolyl hydroxylase inhibitors daprodustat, desidustat, and vadadustat for equine doping control.
Philip M; Karakka Kal AK; Subhahar MB; Karatt TK; Mathew B; Perwad Z
Drug Test Anal; 2022 Feb; 14(2):317-348. PubMed ID: 34714596
[TBL] [Abstract][Full Text] [Related]
8. Detection of recombinant insulins in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns.
Mazzarino M; Senofonte M; Martinelli F; de la Torre X; Botrè F
Anal Bioanal Chem; 2019 Dec; 411(30):8153-8162. PubMed ID: 31797014
[TBL] [Abstract][Full Text] [Related]
9. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
Kwok WH; Choi TLS; Tsoi YYK; Leung GNW; Wan TSM
J Chromatogr A; 2017 Mar; 1490():89-101. PubMed ID: 28215405
[TBL] [Abstract][Full Text] [Related]
10. A sensitive assay for ZYAN1 in human whole blood and urine utilizing positive LC-MS/MS electrospray ionization.
Patel H; Soni K; Trivedi R; Heading H; Geue J; Kansagra K; Gupta RJ; Pandya VB; Srinivas NR; Patel PR; Desai RC
Bioanalysis; 2017 May; 9(9):719-732. PubMed ID: 28488896
[TBL] [Abstract][Full Text] [Related]
11. Screening and confirmation analysis of stimulants, narcotics and beta-adrenergic agents in human urine by hydrophilic interaction liquid chromatography coupled to mass spectrometry.
Mazzarino M; Fiacco I; de la Torre X; Botrè F
J Chromatogr A; 2011 Nov; 1218(45):8156-67. PubMed ID: 21978955
[TBL] [Abstract][Full Text] [Related]
12. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.
Philip M; Mathew B; Karatt TK; Perwad Z; Subhahar MB; Karakka Kal AK
Drug Test Anal; 2021 Apr; 13(4):794-816. PubMed ID: 33458935
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-tandem mass spectrometry methods for quantification of roxadustat (FG-4592) in human plasma and urine and the applications in two clinical pharmacokinetic studies.
Zheng X; Chen X; Liu T; Jiang J; Cui X; Zhao Q; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1203():123274. PubMed ID: 35662878
[TBL] [Abstract][Full Text] [Related]
14. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents.
Ventura R; Roig M; Montfort N; Sáez P; Bergés R; Segura J
Eur J Mass Spectrom (Chichester); 2008; 14(3):191-200. PubMed ID: 18708699
[TBL] [Abstract][Full Text] [Related]
15. Screening method for stimulants in urine by UHPLC-MS/MS: identification of isomeric compounds.
Monfort N; Martínez L; Bergés R; Segura J; Ventura R
Drug Test Anal; 2015 Sep; 7(9):819-30. PubMed ID: 25728759
[TBL] [Abstract][Full Text] [Related]
16. [Screening and quantitative analysis of nine illicit antiallergics in emulsion cosmetics by ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry].
Wang M; Chen Y; Tu F; Hou J; Yang M; Lu Y; Wang Y; Yang Z; Chen D
Se Pu; 2020 Dec; 38(12):1423-1430. PubMed ID: 34213257
[TBL] [Abstract][Full Text] [Related]
17. [Determination of eight environmental phenols in human urine samples by high-throughput solid-phase extraction-ultra-performance liquid chromatography-tandem mass spectrometry].
Lin X; Qiu T; Zhang X; Hu X; Yang Y; Zhu Y
Se Pu; 2020 Dec; 38(12):1456-1464. PubMed ID: 34213261
[TBL] [Abstract][Full Text] [Related]
18. A validated method for the quantification of IOX-2, a potent prolyl hydroxylase inhibitor in equine urine and plasma using liquid chromatography-high-resolution mass spectrometry.
Mikhail E; Siccardi E; Bawazir A; Rajesh A; Prathyush S; Al Wazani DMK; Sabeek M; John T
Drug Test Anal; 2021 Jun; 13(6):1178-1190. PubMed ID: 33533201
[TBL] [Abstract][Full Text] [Related]
19. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.
Dib J; Mongongu C; Buisson C; Molina A; Schänzer W; Thuss U; Thevis M
Drug Test Anal; 2017 Jan; 9(1):61-67. PubMed ID: 27346747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
